These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. D-penicillamine-induced pemphigus vulgaris in a patient with scleroderma-rheumatoid arthritis overlap syndrome. Szegedi A; Surányi P; Szücs G; Kiss M; Hunyadi J; Gaál J Acta Derm Venereol; 2004; 84(4):318-9. PubMed ID: 15339083 [No Abstract] [Full Text] [Related]
23. D-penicillamine: chemistry and clinical use in rheumatic disease. Howard-Lock HE; Lock CJ; Mewa A; Kean WF Semin Arthritis Rheum; 1986 May; 15(4):261-81. PubMed ID: 2940684 [TBL] [Abstract][Full Text] [Related]
24. [Treatment of progressive scleroderma with D-penicillamine (Metalcaptase)]. Böni A; Pavelka K; Kludas M Munch Med Wochenschr; 1969 Aug; 111(31):1580-4. PubMed ID: 5394493 [No Abstract] [Full Text] [Related]
25. Decreased taste sensitivity after D-penicillamine reversed by copper administration. Henkin RI; Keiser HR; Jafee IA; Sternlieb I; Scheinberg IH Lancet; 1967 Dec; 2(7529):1268-71. PubMed ID: 4168610 [No Abstract] [Full Text] [Related]
26. [Effects and adverse effects of D-penicillamine]. Perings E; Junge U Med Klin; 1975 Aug; 70(31):1265-74. PubMed ID: 1107780 [No Abstract] [Full Text] [Related]
27. [Penicillamine in the treatment of scleroderma. Lathyrogenic drugs]. Szczepanski A Przegl Dermatol; 1971; 58(3):355-9. PubMed ID: 4944035 [No Abstract] [Full Text] [Related]
28. Reaction to D-penicillamine in rheumatoid arthritis. Day AT; Golding JR Br Med J; 1973 Sep; 3(5880):593. PubMed ID: 4726943 [No Abstract] [Full Text] [Related]
29. The use of penicillamine in the treatment of rheumatoid arthritis and scleroderma. Baum J Scand J Rheumatol Suppl; 1979; (28):65-70. PubMed ID: 377472 [TBL] [Abstract][Full Text] [Related]
30. D-penicillamine in the treatment of localized scleroderma. Falanga V; Medsger TA Arch Dermatol; 1990 May; 126(5):609-12. PubMed ID: 2334179 [TBL] [Abstract][Full Text] [Related]
31. [D-penicillamine in rheumatoid arthritis : hematological incidents and accidents (author's transl)]. Franck JL; Bouteiller G; Gayrard M; Arlet J Sem Hop; 1979 Sep 8-15; 55(27-30):1325-7. PubMed ID: 228408 [TBL] [Abstract][Full Text] [Related]
34. [Penicillamine in the light of current clinical research]. Beritić T; Dimov Lijec Vjesn; 1970 Dec; 92(12):1449-53. PubMed ID: 5002621 [No Abstract] [Full Text] [Related]
35. Effects of penicillamine on the kidney and on taste. Jaffe IA Postgrad Med J; 1968 Oct; ():Suppl:15-8. PubMed ID: 5706604 [No Abstract] [Full Text] [Related]
36. [Investigations on the mode of action of D-penicillamine (Metalcaptase) in sclerodermia]. Daróczy J; Gyöngyvér S Munch Med Wochenschr; 1973 Aug; 115(31):1363-7. PubMed ID: 4741080 [No Abstract] [Full Text] [Related]
38. Transient acantholytic dermatosis (Grover's disease) in a patient with progressive systemic sclerosis treated with D-penicillamine. Zvulunov A; Grunwald MH; Avinoach I; Halevy S Int J Dermatol; 1997 Jun; 36(6):476-7. PubMed ID: 9248901 [No Abstract] [Full Text] [Related]
39. [D-penicillamine therapy of chronic polyarthritis]. Günther R; Gabl F; Knapp E Z Rheumaforsch; 1973; 32(7):313-25. PubMed ID: 4741805 [No Abstract] [Full Text] [Related]
40. The toxicity pattern of D-penicillamine therapy. A guide to its use in rheumatoid arthritis. Kean WF; Dwosh IL; Anastassiades TP; Ford PM; Kelly HG Arthritis Rheum; 1980 Feb; 23(2):158-64. PubMed ID: 7362666 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]